Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed schedule of Analyst/ Institutional Investor Meetings with the Company to be held on 12th, 14th and 15th September 2022.
The above information is a part of company’s filings submitted to BSE.